Ozark Center/New Directions is a licensed substance use treatment provider in Joplin, MO, listed in the SAMHSA treatment directory. Clients can live on site in a residential program while they complete treatment. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Substance use treatmentDetoxificationTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentCommission on Accreditation of Rehabilitation Facilities (CARF)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
3220 South Wisconsin Avenue, Suite C, Joplin, MO 64804
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare